0001437749-22-019663.txt : 20220809 0001437749-22-019663.hdr.sgml : 20220809 20220809185829 ACCESSION NUMBER: 0001437749-22-019663 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220807 FILED AS OF DATE: 20220809 DATE AS OF CHANGE: 20220809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 221149911 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 1000 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 rdgdoc.xml FORM 4 X0306 4 2022-08-07 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 1 Chief Executive Officer Common Stock 2022-08-07 4 M 0 16918 0 A 251960 D Common Stock 2022-08-07 4 F 0 11557 382.97 D 240403 D Common Stock 100 I By Step-Son Common Stock 100 I By Step-Daughter Stock Options (Right to Buy) 106.5900 2023-08-18 Common Stock 256010 256010 D Stock Options (Right to Buy) 125.0500 2024-08-09 Common Stock 194771 194771 D Stock Options (Right to Buy) 177.3200 2025-08-08 Common Stock 90334 90334 D Stock Options (Right to Buy) 177.3200 2025-08-08 Common Stock 60222 60222 D Restricted Stock Units 2022-08-07 4 M 0 16937 0 D Common Stock 16937 0 D Stock Options (Right to Buy) 190.4100 2026-08-07 Common Stock 85725 85725 D Stock Options (Right to Buy) 190.4100 2026-08-07 Common Stock 57150 57150 D Restricted Stock Units Common Stock 12879 12879 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 57442 57442 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 38295 38295 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 16650 16650 D Stock Options (Right to Buy) 267.8700 2027-08-05 Common Stock 16650 16650 D Restricted Stock Units Common Stock 8016 8016 D Stock Options (Right to Buy) 481.8200 2028-08-06 Common Stock 31315 31315 D Stock Options (Right to Buy) 481.8200 2028-08-06 Common Stock 20876 20876 D Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024. Fully exercisable. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. On 8/7/2022, the Board of Directors certified vesting of 16,937 performance RSUs. Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021. Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025. /s/ Brenda S. Furlow, Attorney-in-Fact 2022-08-09